Mindray Medical International Limited (MR): Health Services' Featured Underperformer Of The Day

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Mindray Medical International ( MR) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.5%. By the end of trading, Mindray Medical International fell 41 cents (-1%) to $39.94 on average volume. Throughout the day, 613,482 shares of Mindray Medical International exchanged hands as compared to its average daily volume of 801,000 shares. The stock ranged in price between $39.88-$40.50 after having opened the day at $40.05 as compared to the previous trading day's close of $40.35. Other companies within the Health Services industry that declined today were: Retractable Technologies ( RVP), down 12.4%, Vanguard Health Systems ( VHS), down 7.3%, Thermogenesis Corporation ( KOOL), down 6.6%, and Uroplasty ( UPI), down 4.6%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray, develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. Mindray Medical International has a market cap of $4.69 billion and is part of the health care sector. The company has a P/E ratio of 22.1, above the S&P 500 P/E ratio of 17.7. Shares are up 23.4% year to date as of the close of trading on Wednesday. Currently there are six analysts that rate Mindray Medical International a buy, no analysts rate it a sell, and one rates it a hold.

TheStreet Ratings rates Mindray Medical International as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

On the positive front, InfuSystems Holdings ( INFU), up 11%, MGC Diagnostics ( MGCD), up 10.9%, Hooper Holmes ( HH), up 10.8%, and Oculus Innovative ( OCLS), up 9.7%, were all gainers within the health services industry with UnitedHealth Group ( UNH) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.
null

If you liked this article you might like

3 Fallen Angels With Chart Appeal

3 Fallen Angels With Chart Appeal

3 Stocks Driving The Health Services Industry Higher

Mindray Medical (MR) Stock Gains After Receiving 'Going Private' Proposal

Trade-Ideas: Mindray Medical International (MR) Is Today's Weak On High Relative Volume Stock

Mindray Medical International (MR) Downgraded From Buy to Hold